Those most at risk should be eligible for preventative treatment to reduce the chances of it developing, NHS told. More than half a million women at risk of breast cancer should be offered drugs by the NHS for the first time to stop it developing, according to official health advice that could lead to a historic shift from treatment of the country's most common cancer to its prevention.
All women over 30 in England and Wales judged to be at moderate or high risk of breast cancer would be able to take one of two drugs to reduce their risk under the draft guideline drawn up by the National Institute for Health and Clinical Excellence (Nice).
Read the full story: http://bit.ly/Xzoldn
Source: Oncology Business Review
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen